Short Interest in Aimei Health Technology Co., Ltd (NASDAQ:AFJK) Declines By 94.1%

Aimei Health Technology Co., Ltd (NASDAQ:AFJK) was the target of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 100 shares, a decrease of 94.1% from the January 31st total of 1,700 shares. Based on an average trading volume of 54,100 shares, the days-to-cover ratio is currently 0.0 days.

Institutional Trading of Aimei Health Technology

Several large investors have recently made changes to their positions in AFJK. Virtu Financial LLC acquired a new position in Aimei Health Technology during the 3rd quarter worth approximately $123,000. Harraden Circle Investments LLC bought a new stake in shares of Aimei Health Technology during the fourth quarter valued at approximately $1,117,000. Quarry LP acquired a new position in shares of Aimei Health Technology during the fourth quarter worth approximately $1,605,000. Rivernorth Capital Management LLC lifted its holdings in shares of Aimei Health Technology by 9.1% in the 3rd quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company’s stock worth $1,811,000 after purchasing an additional 14,391 shares in the last quarter. Finally, Centiva Capital LP grew its position in Aimei Health Technology by 1.4% in the 4th quarter. Centiva Capital LP now owns 232,693 shares of the company’s stock valued at $2,460,000 after purchasing an additional 3,100 shares during the period. 45.58% of the stock is currently owned by institutional investors and hedge funds.

Aimei Health Technology Stock Performance

NASDAQ:AFJK opened at $10.93 on Friday. Aimei Health Technology has a 12 month low of $10.15 and a 12 month high of $11.00. The firm has a fifty day simple moving average of $10.78 and a two-hundred day simple moving average of $10.61.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.